TickerFacts.

CytoDyn Inc. (CYDY): Capital Expenditures

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2019-05-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest Capital Expenditures is for the year ended 2021-05-31, while the company's latest annual report covers the year ended 2026-05-31. Its later filings do not report this line under the concept TickerFacts maps.

$122.0K
Year ended 2021-05-31
2011-05-31: $4.7K2013-05-31: $3.1K2014-05-31: $19.2K2015-05-31: $18.6K2016-05-31: $11.9K2017-05-31: $11.1K2018-05-31: $02019-05-31: $26.0K2020-05-31: $41.0K2021-05-31: $122.0K$122.0K
2011-05-31 Capital Expenditures (USD) 2021-05-31
Period endedCapital ExpendituresChange YoYSource filing
2021-05-31$122.0K+197.6%2022-08-15, From 2020-06-01
2020-05-31$41.0K+57.7%2022-08-15, From 2019-06-01
2019-05-31$26.0Kn/c2021-07-30, From 2018-06-01
2018-05-31$0-100.0%2019-08-14, From 2017-06-01
2017-05-31$11.1K-7.0%2019-08-14, From 2016-06-01
2016-05-31$11.9K-35.7%2018-07-27, From 2015-06-01
2015-05-31$18.6K-3.3%2016-07-19, From 2014-06-01
2014-05-31$19.2K+513.1%2015-07-10, From 2013-06-01
2013-05-31$3.1Kn/a2014-07-10, From 2012-06-01
No annual figure between 2011-05-31 and 2013-05-31.
2011-05-31$4.7Kn/a2012-08-22, From 2010-06-01